Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia

Carlos Salama, Jian Han, Linda Yau, William G. Reiss, Benjamin Kramer, Jeffrey D. Neidhart, Gerard J. Criner, Emma Kaplan-Lewis, Rachel Baden, Lavannya Pandit, Miriam L. Cameron, Julia Garcia-Diaz, Victoria Chávez, Martha Mekebeb-Reuter, Ferdinando Lima Menezes, Reena Shah, Maria F. González-Lara, Beverly Assman, Jamie Freedman, Shalini V. Mohan
doi: https://doi.org/10.1101/2020.10.21.20210203
Carlos Salama
1Elmhurst Hospital Center—Icahn School of Medicine at the Mount Sinai Hospital, Elmhurst, NY, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Han
2Genentech, South San Francisco, CA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Yau
2Genentech, South San Francisco, CA, USA
MPhil, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William G. Reiss
2Genentech, South San Francisco, CA, USA
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Kramer
2Genentech, South San Francisco, CA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey D. Neidhart
3San Juan Oncology Associates, Farmington, NM, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard J. Criner
4Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Kaplan-Lewis
5Elmhurst Hospital Center—New York City Health and Hospitals, Elmhurst, NY, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Baden
6Highland Hospital, Oakland, CA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lavannya Pandit
7Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam L. Cameron
8Holy Cross Health, Silver Spring, MD, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Garcia-Diaz
9Ochsner Clinic Foundation, New Orleans, LA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victoria Chávez
10Central Military Hospital, Lima, Peru
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martha Mekebeb-Reuter
11Stellenbosch University, Cape Town, South Africa
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferdinando Lima Menezes
12BR Trials - Pesquisa Clínica, Sao Paulo, SP, Brazil
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reena Shah
13Aga Khan University Hospital, Nairobi, Kenya
MScID, FRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria F. González-Lara
14Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverly Assman
2Genentech, South San Francisco, CA, USA
BSc, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamie Freedman
2Genentech, South San Francisco, CA, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shalini V. Mohan
2Genentech, South San Francisco, CA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mohan.shalini@gene.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated with hyperinflammation. Safety and efficacy of the anti–interleukin-6 receptor antibody tocilizumab was evaluated in patients hospitalized with Covid-19 pneumonia.

Methods Nonventilated patients hospitalized with Covid-19 pneumonia were randomized (2:1) to tocilizumab (8 mg/kg intravenous) or placebo plus standard care. Sites enrolling high-risk and minority populations were emphasized. The primary endpoint was cumulative proportion of patients requiring mechanical ventilation or who had died by Day 28.

Results Of 389 randomized patients, 249 patients received tocilizumab and 128 received placebo in the modified intent-to-treat population (Hispanic/Latino, 56.0%; Black/African American, 14.9%; American Indian/Alaska Native, 12.7%; White, 12.7%; other/unknown, 3.7%). The cumulative proportion (95% confidence interval [CI]) of patients requiring mechanical ventilation or who had died by Day 28 was 12.0% (8.52% to 16.86%) and 19.3 % (13.34% to 27.36%) for the tocilizumab and placebo arms, respectively (log-rank P=0.0360; hazard ratio, 0.56 [95% CI, 0.33 to 0.97]). Median time to clinical failure up to Day 28 favored tocilizumab over placebo (hazard ratio 0.55 [95% CI, 0.33 to 0.93]). All-cause mortality by Day 28 was 10.4% with tocilizumab and 8.6% with placebo (weighted difference, 2.0% [95% CI, – 5.2% to 7.8%). In the safety population, serious adverse events occurred in 15.2% of tocilizumab patients (38/250 patients) and 19.7% of placebo patients (25/127).

Conclusions This trial demonstrated the efficacy and safety of tocilizumab over placebo in reducing the likelihood of progression to requiring mechanical ventilation or death in nonventilated patients hospitalized with Covid-19 pneumonia.

Trial registration ClinicalTrials.gov NCT04372186

Competing Interest Statement

C.S. reports personal fees from Genentech, Inc. J.H., L.Y., W.G.R., B.K., and S.V.M are employees and shareholders of Genentech, Inc. and have filed a patent for a method of treating pneumonia, including COVID-19 pneumonia, with an IL-6 antagonist. J.D.N., L.P., M.L.C., J.G.-D., V.C., M.M.-R., F.L.M., and R.S. have nothing to disclose. G.J.C. reports, outside the submitted work, grants and personal fees from Galaxo Smith Kline, Boehringer Ingelheim, Chiesi, Mereo, Astra Zeneca, Pulmonx, Pneumrx, Olympus, Broncus, Lungpacer, Nuvaira, ResMed, Respironics, and Patara; personal fees from Verona, BTG, EOLO, and NGM; grants from Alung, Fisher Paykel, and Galapgos. E.K.-L. reports honorarium from ViiV outside the submitted work and is a site PI for a Genentech, Inc. sponsored clinical trial. R.B. reports her institution received support from Genentech, Inc. to perform this study. M.F.G.-L. reports personal fees from Pfizer, Stendhal, and Grupo Biotoscana during the conduct of the study and personal fees from Pfizer and Stendhal outside the submitted work. B.A. and J.F. are employees and shareholders of Genentech, Inc.

Clinical Trial

NCT04372186

Funding Statement

This study was funded by Genentech, Inc.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All patients or their legally authorized representative gave informed consent. This study was conducted in accordance with the International Council for Harmonization E6 guideline for good clinical practice and the Declaration of Helsinki or local regulations, whichever afforded greater patient protection. This study was approved by all study sites though the central institutional review boards Advarra Institutional Review Board or Western Institutional Review Board, and/or the following local ethics committees/institutional review boards: Aga Khan University Hospital Nairobi, COFEPRIS, Comité de Bioseguridad de Clínica Bajío CLINBA, S.C., Comité de Bioseguridad del Institut Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Comitě de ética em Pesquisa da Faculdade de Medicina do ABC, Comitě de ética em Pesquisa em Seres Humanos Pontifícia Univesidade Católica de Campinas - PUC CAMPI, Comite de Etica en Investigacion del Hospital General de Culiacan Dr Bernardo J Gastelum, Comité de ética Investigación Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Comite Nacional Transitorio de Etica de los Ensayos COVID-19, Ministerio de Salud Instituto Nacional de Salud, PPB ECCT, Sharp Healthcare Institutional Review Board, and St. Joseph Health Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Qualified researchers may request access to individual patient level data through the clinical study data request platform (https://vivli.org/). Further details on Roche's criteria for eligible studies are available here (https://vivli.org/members/ourmembers/). For further details on Roche's Global Policy on the Sharing of Clinical Information and how to request access to related clinical study documents, see here (https://www.roche.com/research_and_development/who_we_are_how_we_work/clinical_trials/our_commitment_to_data_sharing.htm).

https://vivli.org/

https://vivli.org/members/ourmembers/

https://www.roche.com/research_and_development/who_we_are_how_we_work/clinical_trials/our_commitment_to_data_sharing.htm

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia
Carlos Salama, Jian Han, Linda Yau, William G. Reiss, Benjamin Kramer, Jeffrey D. Neidhart, Gerard J. Criner, Emma Kaplan-Lewis, Rachel Baden, Lavannya Pandit, Miriam L. Cameron, Julia Garcia-Diaz, Victoria Chávez, Martha Mekebeb-Reuter, Ferdinando Lima Menezes, Reena Shah, Maria F. González-Lara, Beverly Assman, Jamie Freedman, Shalini V. Mohan
medRxiv 2020.10.21.20210203; doi: https://doi.org/10.1101/2020.10.21.20210203
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia
Carlos Salama, Jian Han, Linda Yau, William G. Reiss, Benjamin Kramer, Jeffrey D. Neidhart, Gerard J. Criner, Emma Kaplan-Lewis, Rachel Baden, Lavannya Pandit, Miriam L. Cameron, Julia Garcia-Diaz, Victoria Chávez, Martha Mekebeb-Reuter, Ferdinando Lima Menezes, Reena Shah, Maria F. González-Lara, Beverly Assman, Jamie Freedman, Shalini V. Mohan
medRxiv 2020.10.21.20210203; doi: https://doi.org/10.1101/2020.10.21.20210203

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1944)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (698)
  • Epidemiology (11100)
  • Forensic Medicine (8)
  • Gastroenterology (623)
  • Genetic and Genomic Medicine (3164)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12717)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2984)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1550)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2782)
  • Public and Global Health (5590)
  • Radiology and Imaging (1093)
  • Rehabilitation Medicine and Physical Therapy (632)
  • Respiratory Medicine (759)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)